Hass David J, Kozuch Patricia, Brandt Lawrence J
Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York 10467, USA.
Am J Gastroenterol. 2007 Aug;102(8):1765-80. doi: 10.1111/j.1572-0241.2007.01260.x. Epub 2007 May 3.
Colon ischemia (CI) is the most common form of ischemic injury of the gastrointestinal tract. Determining the precise incidence of CI is a challenging task, because of its often brief, mild nature, and frequent spontaneous resolution, as well as its misdiagnosis as other diseases. While many underlying disease conditions may predispose patients to CI, an important and possibly overlooked etiology is that of pharmacologically induced alterations of colonic blood flow. This review details the pharmacologic agents known to be associated with CI; when possible, their mechanisms of action are described. The aim of this paper is to highlight this often unrecognized cause of CI, thereby helping physicians to be aware of the association, to recognize its occurrence promptly, and to possibly reduce morbidity and mortality.
结肠缺血(CI)是胃肠道缺血性损伤最常见的形式。由于CI通常病程短暂、症状轻微且常能自发缓解,同时还易被误诊为其他疾病,因此准确确定其发病率是一项具有挑战性的任务。虽然许多潜在疾病状况可能使患者易患CI,但一个重要且可能被忽视的病因是药物引起的结肠血流改变。本综述详细介绍了已知与CI相关的药物;并尽可能描述了它们的作用机制。本文的目的是强调这种常未被认识到的CI病因,从而帮助医生了解这种关联,及时识别其发生情况,并可能降低发病率和死亡率。